Skip to main content
PMC home page
Journal of Neurology, Neurosurgery, and Psychiatry logoLink to Journal of Neurology, Neurosurgery, and Psychiatry
. 2004 Aug;75(8):1100–1106. doi: 10.1136/jnnp.2003.028076

Premorbid cognitive testing predicts the onset of dementia and Alzheimer's disease better than and independently of APOE genotype

J Cervilla 1, M Prince 1, S Joels 1, S Lovestone 1, A Mann 1
PMCID: PMC1739178  PMID: 15258208

Abstract

Objective: To determine whether a cognitive test package can predict the onset of dementia up to 11 years later, and the extent to which this prediction is independent of that provided by APOE genotype.

Methods: Prospective cohort study based on 54 general practices in the UK; 657 survivors of the 1088 participants in the MRC treatment trial of hypertension in older adults were followed for up to 11 years; 370 participants (57% of survivors) were traced, screened for dementia, and genotyped for APOE in 1994. Baseline assessments included trail making test A, paired associated learning test, Raven's progressive matrices, and national adult reading test. At follow up, both mini-mental state examination and CAMCOG were used. Outcome measures were DSM-IIIR dementia and NINCDS-ADRDA possible and probable Alzheimer's disease.

Results: All the cognitive tests completed in 1983 predicted onset of dementia and Alzheimer's disease up to 11 years later, as did APOE genotype. Cognitive test performance was not associated with APOE genotype. Addition of cognitive tests increased the area under the ROC curve for the prediction of Alzheimer's disease provided by age, family history, and APOE genotype (0.81 v 0.69, p = 0.048); addition of APOE genotype did not increase the area under the ROC curve for the prediction provided by age, family history, and cognitive tests (0.81 v 0.77, p = 0.28).

Conclusions: Simple tests of cognitive ability provide useful predictive information up to a decade before the onset of dementia. The predictive information provided is independent of, but not enhanced by, the addition of APOE genotype.

Full Text

The Full Text of this article is available as a PDF (274.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Andersen K., Launer L. J., Ott A., Hoes A. W., Breteler M. M., Hofman A. Do nonsteroidal anti-inflammatory drugs decrease the risk for Alzheimer's disease? The Rotterdam Study. Neurology. 1995 Aug;45(8):1441–1445. doi: 10.1212/wnl.45.8.1441. [DOI] [PubMed] [Google Scholar]
  2. Asthana S., Baker L. D., Craft S., Stanczyk F. Z., Veith R. C., Raskind M. A., Plymate S. R. High-dose estradiol improves cognition for women with AD: results of a randomized study. Neurology. 2001 Aug 28;57(4):605–612. doi: 10.1212/wnl.57.4.605. [DOI] [PubMed] [Google Scholar]
  3. Bottino C. M., Almeida O. P. Can neuroimaging techniques identify individuals at risk of developing Alzheimer's disease? Int Psychogeriatr. 1997 Dec;9(4):389–403. doi: 10.1017/s1041610297004535. [DOI] [PubMed] [Google Scholar]
  4. Bowen J., Teri L., Kukull W., McCormick W., McCurry S. M., Larson E. B. Progression to dementia in patients with isolated memory loss. Lancet. 1997 Mar 15;349(9054):763–765. doi: 10.1016/S0140-6736(96)08256-6. [DOI] [PubMed] [Google Scholar]
  5. Braak H., Braak E. Evolution of neuronal changes in the course of Alzheimer's disease. J Neural Transm Suppl. 1998;53:127–140. doi: 10.1007/978-3-7091-6467-9_11. [DOI] [PubMed] [Google Scholar]
  6. Bäckman L., Small B. J., Fratiglioni L. Stability of the preclinical episodic memory deficit in Alzheimer's disease. Brain. 2001 Jan;124(Pt 1):96–102. doi: 10.1093/brain/124.1.96. [DOI] [PubMed] [Google Scholar]
  7. Centor R. M. A Visicalc program for estimating the area under a receiver operating characteristic (ROC) curve. Med Decis Making. 1985 Summer;5(2):139–148. doi: 10.1177/0272989X8500500203. [DOI] [PubMed] [Google Scholar]
  8. Cervilla J. A., Prince M., Joels S., Lovestone S., Mann A. Long-term predictors of cognitive outcome in a cohort of older people with hypertension. Br J Psychiatry. 2000 Jul;177:66–71. doi: 10.1192/bjp.177.1.66. [DOI] [PubMed] [Google Scholar]
  9. Chen P., Ratcliff G., Belle S. H., Cauley J. A., DeKosky S. T., Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 2000 Dec 26;55(12):1847–1853. doi: 10.1212/wnl.55.12.1847. [DOI] [PubMed] [Google Scholar]
  10. Chen P., Ratcliff G., Belle S. H., Cauley J. A., DeKosky S. T., Ganguli M. Cognitive tests that best discriminate between presymptomatic AD and those who remain nondemented. Neurology. 2000 Dec 26;55(12):1847–1853. doi: 10.1212/wnl.55.12.1847. [DOI] [PubMed] [Google Scholar]
  11. Copeland J. R., Dewey M. E., Griffiths-Jones H. M. A computerized psychiatric diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. Psychol Med. 1986 Feb;16(1):89–99. doi: 10.1017/s0033291700057779. [DOI] [PubMed] [Google Scholar]
  12. Deary Ian J., Whiteman Martha C., Pattie Alison, Starr John M., Hayward Caroline, Wright Alan F., Carothers Andrew, Whalley Lawrence J. Cognitive change and the APOE epsilon 4 allele. Nature. 2002 Aug 29;418(6901):932–932. doi: 10.1038/418932a. [DOI] [PubMed] [Google Scholar]
  13. Elias M. F., Beiser A., Wolf P. A., Au R., White R. F., D'Agostino R. B. The preclinical phase of alzheimer disease: A 22-year prospective study of the Framingham Cohort. Arch Neurol. 2000 Jun;57(6):808–813. doi: 10.1001/archneur.57.6.808. [DOI] [PubMed] [Google Scholar]
  14. Folstein M. F., Folstein S. E., McHugh P. R. "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975 Nov;12(3):189–198. doi: 10.1016/0022-3956(75)90026-6. [DOI] [PubMed] [Google Scholar]
  15. Hanley J. A., McNeil B. J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983 Sep;148(3):839–843. doi: 10.1148/radiology.148.3.6878708. [DOI] [PubMed] [Google Scholar]
  16. Hanley J. A., McNeil B. J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982 Apr;143(1):29–36. doi: 10.1148/radiology.143.1.7063747. [DOI] [PubMed] [Google Scholar]
  17. Hirono N., Hashimoto M., Yasuda M., Ishii K., Sakamoto S., Kazui H., Mori E. The effect of APOE epsilon4 allele on cerebral glucose metabolism in AD is a function of age at onset. Neurology. 2002 Mar 12;58(5):743–750. doi: 10.1212/wnl.58.5.743. [DOI] [PubMed] [Google Scholar]
  18. INGLIS J. A paired-associate learning test for use with elderly psychiatric patients. J Ment Sci. 1959 Apr;105(439):440–443. doi: 10.1192/bjp.105.439.440. [DOI] [PubMed] [Google Scholar]
  19. Jack C. R., Jr, Petersen R. C., Xu Y., O'Brien P. C., Smith G. E., Ivnik R. J., Tangalos E. G., Kokmen E. Rate of medial temporal lobe atrophy in typical aging and Alzheimer's disease. Neurology. 1998 Oct;51(4):993–999. doi: 10.1212/wnl.51.4.993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Masur D. M., Fuld P. A., Blau A. D., Crystal H., Aronson M. K. Predicting development of dementia in the elderly with the Selective Reminding Test. J Clin Exp Neuropsychol. 1990 Aug;12(4):529–538. doi: 10.1080/01688639008400999. [DOI] [PubMed] [Google Scholar]
  21. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E. M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology. 1984 Jul;34(7):939–944. doi: 10.1212/wnl.34.7.939. [DOI] [PubMed] [Google Scholar]
  22. Nelson H. E., O'Connell A. Dementia: the estimation of premorbid intelligence levels using the New Adult Reading Test. Cortex. 1978 Jun;14(2):234–244. doi: 10.1016/s0010-9452(78)80049-5. [DOI] [PubMed] [Google Scholar]
  23. Palmer Katie, Bäckman Lars, Winblad Bengt, Fratiglioni Laura. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ. 2003 Feb 1;326(7383):245–245. doi: 10.1136/bmj.326.7383.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Palmer Katie, Bäckman Lars, Winblad Bengt, Fratiglioni Laura. Detection of Alzheimer's disease and dementia in the preclinical phase: population based cohort study. BMJ. 2003 Feb 1;326(7383):245–245. doi: 10.1136/bmj.326.7383.245. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Prince M. J. Predicting the onset of Alzheimer's disease using Bayes' theorem. Am J Epidemiol. 1996 Feb 1;143(3):301–308. doi: 10.1093/oxfordjournals.aje.a008742. [DOI] [PubMed] [Google Scholar]
  26. Prince M., Cullen M., Mann A. Risk factors for Alzheimer's disease and dementia: a case-control study based on the MRC elderly hypertension trial. Neurology. 1994 Jan;44(1):97–104. doi: 10.1212/wnl.44.1.97. [DOI] [PubMed] [Google Scholar]
  27. Prince M. Is chronic low-level lead exposure in early life an etiologic factor in Alzheimer's disease? Epidemiology. 1998 Nov;9(6):618–621. [PubMed] [Google Scholar]
  28. Prince M., Lovestone S., Cervilla J., Joels S., Powell J., Russ C., Mann A. The association between APOE and dementia does not seem to be mediated by vascular factors. Neurology. 2000 Jan 25;54(2):397–402. doi: 10.1212/wnl.54.2.397. [DOI] [PubMed] [Google Scholar]
  29. Reiman E. M., Uecker A., Caselli R. J., Lewis S., Bandy D., de Leon M. J., De Santi S., Convit A., Osborne D., Weaver A. Hippocampal volumes in cognitively normal persons at genetic risk for Alzheimer's disease. Ann Neurol. 1998 Aug;44(2):288–291. doi: 10.1002/ana.410440226. [DOI] [PubMed] [Google Scholar]
  30. Relkin N. R., Kwon Y. J., Tsai J., Gandy S. The National Institute on Aging/Alzheimer's Association recommendations on the application of apolipoprotein E genotyping to Alzheimer's disease. Ann N Y Acad Sci. 1996 Dec 16;802:149–176. doi: 10.1111/j.1749-6632.1996.tb32608.x. [DOI] [PubMed] [Google Scholar]
  31. Román G. C., Tatemichi T. K., Erkinjuntti T., Cummings J. L., Masdeu J. C., Garcia J. H., Amaducci L., Orgogozo J. M., Brun A., Hofman A. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology. 1993 Feb;43(2):250–260. doi: 10.1212/wnl.43.2.250. [DOI] [PubMed] [Google Scholar]
  32. Roth M., Tym E., Mountjoy C. Q., Huppert F. A., Hendrie H., Verma S., Goddard R. CAMDEX. A standardised instrument for the diagnosis of mental disorder in the elderly with special reference to the early detection of dementia. Br J Psychiatry. 1986 Dec;149:698–709. doi: 10.1192/bjp.149.6.698. [DOI] [PubMed] [Google Scholar]
  33. Snowdon D. A., Kemper S. J., Mortimer J. A., Greiner L. H., Wekstein D. R., Markesbery W. R. Linguistic ability in early life and cognitive function and Alzheimer's disease in late life. Findings from the Nun Study. JAMA. 1996 Feb 21;275(7):528–532. [PubMed] [Google Scholar]
  34. Soininen H. S., Scheltens P. Early diagnostic indices for the prevention of Alzheimer's disease. Ann Med. 1998 Dec;30(6):553–559. doi: 10.3109/07853899809002604. [DOI] [PubMed] [Google Scholar]
  35. St George-Hyslop P. H., Westaway D. A. Alzheimer's disease. Antibody clears senile plaques. Nature. 1999 Jul 8;400(6740):116–117. doi: 10.1038/22006. [DOI] [PubMed] [Google Scholar]
  36. Stern Y., Gurland B., Tatemichi T. K., Tang M. X., Wilder D., Mayeux R. Influence of education and occupation on the incidence of Alzheimer's disease. JAMA. 1994 Apr 6;271(13):1004–1010. [PubMed] [Google Scholar]
  37. Stern Y., Tang M. X., Denaro J., Mayeux R. Increased risk of mortality in Alzheimer's disease patients with more advanced educational and occupational attainment. Ann Neurol. 1995 May;37(5):590–595. doi: 10.1002/ana.410370508. [DOI] [PubMed] [Google Scholar]
  38. Stewart W. F., Kawas C., Corrada M., Metter E. J. Risk of Alzheimer's disease and duration of NSAID use. Neurology. 1997 Mar;48(3):626–632. doi: 10.1212/wnl.48.3.626. [DOI] [PubMed] [Google Scholar]
  39. Tierney M. C., Szalai J. P., Snow W. G., Fisher R. H., Nores A., Nadon G., Dunn E., St George-Hyslop P. H. Prediction of probable Alzheimer's disease in memory-impaired patients: A prospective longitudinal study. Neurology. 1996 Mar;46(3):661–665. doi: 10.1212/wnl.46.3.661. [DOI] [PubMed] [Google Scholar]
  40. Turic D., Fisher P. J., Plomin R., Owen M. J. No association between apolipoprotein E polymorphisms and general cognitive ability in children. Neurosci Lett. 2001 Feb 16;299(1-2):97–100. doi: 10.1016/s0304-3940(00)01789-4. [DOI] [PubMed] [Google Scholar]
  41. Wilson Robert S., Schneider Julie A., Barnes Lisa L., Beckett Laurel A., Aggarwal Neelum T., Cochran Elizabeth J., Berry-Kravis Elizabeth, Bach Julie, Fox Jacob H., Evans Denis A. The apolipoprotein E epsilon 4 allele and decline in different cognitive systems during a 6-year period. Arch Neurol. 2002 Jul;59(7):1154–1160. doi: 10.1001/archneur.59.7.1154. [DOI] [PubMed] [Google Scholar]
  42. Yaffe K., Sawaya G., Lieberburg I., Grady D. Estrogen therapy in postmenopausal women: effects on cognitive function and dementia. JAMA. 1998 Mar 4;279(9):688–695. doi: 10.1001/jama.279.9.688. [DOI] [PubMed] [Google Scholar]
  43. Yip A. G., Brayne C., Easton D., Rubinsztein D. C., Medical Research Council Cognitive Function Ageing Study (MRC CFAS) Apolipoprotein E4 is only a weak predictor of dementia and cognitive decline in the general population. J Med Genet. 2002 Sep;39(9):639–643. doi: 10.1136/jmg.39.9.639. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Journal of Neurology, Neurosurgery, and Psychiatry are provided here courtesy of BMJ Publishing Group

RESOURCES